Description
IPRAWAR-L Respules is a combination bronchodilator used for the management of obstructive airway disorders. It combines the selective β2-agonist Levosalbutamol with the anticholinergic Ipratropium Bromide, offering dual bronchodilation for effective relief of symptoms in patients with reversible obstructive airway disease.
Mechanism of Action
Levosalbutamol – Acts as a selective β2-adrenergic agonist, producing relaxation of bronchial smooth muscles and rapid bronchodilation.
Ipratropium Bromide – A muscarinic receptor antagonist that inhibits vagally mediated bronchoconstriction, reducing airway resistance.
